Literature DB >> 9302278

Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p.

C Jodice1, E Mantuano, L Veneziano, F Trettel, G Sabbadini, L Calandriello, A Francia, M Spadaro, F Pierelli, F Salvi, R A Ophoff, R R Frants, M Frontali.   

Abstract

Point mutations of the CACNA1A gene coding for the alpha 1A voltage-dependent calcium channel subunit are responsible for familial hemiplegic migraine (FHM) and episodic ataxia type 2 (EA2). In addition, expansions of the CAG repeat motif at the 3' end of the gene, smaller than those responsible for dynamic mutation disorders, were found in patients with a progressive spinocerebellar ataxia, named SCA6. In the present work, the analysis of two new families with small CAG expansions of the CACNA1A gene is presented. In one family, with a clinical diagnosis of EA2, a CAG23 repeat allele segregated in patients showing different interictal symptoms, ranging from nystagmus only to severe progressive cerebellar ataxia. No additional mutations in coding and intron-exon junction sequences in disequilibrium with the CAG expansion were found. In the second family, initially classified as autosomal dominant cerebellar ataxia of unknown type, an inter-generational allele size change showed that a CAG20 allele was associated with an EA2 phenotype and a CAG25 allele with progressive cerebellar ataxia. These results show that EA2 and SCA6 are the same disorder with a high phenotypic variability, at least partly related to the number of repeats, and suggest that the small expansions may not be as stable as previously reported. A refinement of the coding and intron-exon junction sequences of the CACNA1A gene is also provided.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9302278     DOI: 10.1093/hmg/6.11.1973

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  59 in total

Review 1.  Unraveling monogenic channelopathies and their implications for complex polygenic disease.

Authors:  J Jay Gargus
Journal:  Am J Hum Genet       Date:  2003-03-07       Impact factor: 11.025

Review 2.  The complex clinical and genetic classification of inherited ataxias. I. Dominant ataxias.

Authors:  S Di Donato
Journal:  Ital J Neurol Sci       Date:  1998-12

Review 3.  In vivo analysis of voltage-dependent calcium channels.

Authors:  Ling Liu; Theresa A Zwingman; Colin F Fletcher
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

4.  Long-term improvement of paroxysmal dystonic choreathetosis with acetazolamide.

Authors:  Veronique Michel; Florence Riant; Elisabeth Tournier-Lasserve; Dominique Guehl; Alain Lagueny; Bernard Bioulac; Pierre Burbaud
Journal:  J Neurol       Date:  2006-04-28       Impact factor: 4.849

5.  Selective regulation of spontaneous activity of neurons of the deep cerebellar nuclei by N-type calcium channels in juvenile rats.

Authors:  Karina Alviña; Kamran Khodakhah
Journal:  J Physiol       Date:  2008-03-27       Impact factor: 5.182

Review 6.  Critical evaluation of in silico methods for prediction of coiled-coil domains in proteins.

Authors:  Chen Li; Catherine Ching Han Chang; Jeremy Nagel; Benjamin T Porebski; Morihiro Hayashida; Tatsuya Akutsu; Jiangning Song; Ashley M Buckle
Journal:  Brief Bioinform       Date:  2015-07-15       Impact factor: 11.622

7.  4-Aminopyridine improves gait variability in cerebellar ataxia due to CACNA 1A mutation.

Authors:  Roman Schniepp; Max Wuehr; Nibal Ackl; Adrian Danek; Thomas Brandt; Michael Strupp; Klaus Jahn
Journal:  J Neurol       Date:  2011-03-23       Impact factor: 4.849

Review 8.  The spinocerebellar ataxias: order emerges from chaos.

Authors:  Russell L Margolis
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

Review 9.  The cerebellum and migraine.

Authors:  Maurice Vincent; Nouchine Hadjikhani
Journal:  Headache       Date:  2007-06       Impact factor: 5.887

10.  Paroxysmal dyskinesias in mice.

Authors:  Thomas L Shirley; Lekha M Rao; Ellen J Hess; H A Jinnah
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.